Skin Microbiome EU 2018
Skin Microbiome EU 2018
14-15 November, 2018
London, United Kingdom

Translating microbiome research into clinically & commercially viable cosmetics & therapeutics, revolutionizing dermatology.

New | Pre-day Workshop

When you’re looking to develop products in the Skin Microbiome space, there are two main things you know to know: 
 
1. How do I pick ingredients and formulate a product that is effective, scalable and stable?

2. How to I test a product in a reliable and reproducible way to ensure it is clinically safe and effective?

 
New for Europe's first Skin Microbiome Congress in London, 14 - 15 November, you're invited to attend an exclusive pre-event one day workshop. 


Join us on 13 November 2018 for 2 interactive discussions around the formulation and testing of microbiome based products. Learn industry leaders and use the opportunity to get answer to some of the most commonly asked questions and challenges whilst discussing strategies for product development.     

Spaces are limited. Book now.

Sample Attendees include:

Why Attend

SKIN MICROBIOME IS SET TO REVOLUTIONISE DERMATOLOGY

With the European cosmetics industry playing a leading role in science-driven product development and innovation in skincare, we are proud to announce that we are bringing the Skin Microbiome Congress to London, following the success of our sold out inaugural event in Boston.

As new clinical data transpires to support the role of the skin microbiome in common conditions from acne and eczema to dandruff and skin allergies, Pharmaceutical Researchers and Cosmetic Formulators alike are turning their attention to designing and testing products that contain live bacteria, bacterial extracts or prebiotic and postbiotic ingredients to manipulate the skins microbiota.

The European Skin Microbiome Congress will bring together leaders from pharmaceutical, therapeutics and cosmetics industries, to showcase:

• Cutting edge research

• New therapeutic & cosmetic advances

• Consumer trends & insights

• Regulatory considerations

Join 200+ industry leaders to explore the different pathways market and how to translate therapeutic research into commercially viable cosmetic products.

View highlights from the inaugural SOLD OUT
Skin Microbiome Congress, May 30-31, 2018

Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: 

  • Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
  • Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
  • Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
  • Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
  • Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
  • Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product

With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

2
Full conference days
25+
Industry Speakers
200+
Beauty & pharma experts
15+
Dedicated networking hours

Advisory Board

Author:

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

Author:

Shifra Klein

Founder
of Created By___ (formerly Senior Scientist at Johnson & Johnson)

Shifra Klein

Founder
of Created By___ (formerly Senior Scientist at Johnson & Johnson)

Author:

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, and Living Proof. 

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, and Living Proof. 

Author:

Professor Stefan Pelzer

Director Innovation Management Animal Nutrition
Nutrition & Care, Evonik

Professor Stefan Pelzer

Director Innovation Management Animal Nutrition
Nutrition & Care, Evonik

The Speakers

 

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

Marie Drago

Founder
Gallinée

Marie Drago

Founder
Gallinée

Marie Drago is a Doctor in Pharmacy and the founder of Gallinee. Launched in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.

 

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States. 

 

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences.

Dirk Loeffert

CEO
Biomillenia

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences. In 2014, Dirk moved to Paris, France where he co-founded with scientific founders Dave Weitz (Harvard University, Cambridge), Rob Nicol (BROAD Institute, Cambridge) and Andrew Griffiths and Jerome Bibette (both ESPCI Paris, France) BIOMILLENIA.

 

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT.

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, and Living Proof. 

 

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

After finalizing her study of neurobiology at the University of Oldenburg, she conducted a PhD at the Beiersdorf AG in Hamburg, where she afterwards was responsible for the R&D lab “Dry aged skin”.

In 2013, she joined Evonik in the area of Innovation Management for cosmetic active ingredients, where she is now responsible for global marketing.

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

Dr Annika Schrader

Global Marketing Manager Active Ingredients
Evonik Nutrition & Personal Care

After finalizing her study of neurobiology at the University of Oldenburg, she conducted a PhD at the Beiersdorf AG in Hamburg, where she afterwards was responsible for the R&D lab “Dry aged skin”.

In 2013, she joined Evonik in the area of Innovation Management for cosmetic active ingredients, where she is now responsible for global marketing.

 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn

CEO & Founder
Esse Organic Skincare

Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.  

 

 

Dr Marie Alice Dibon

Consultant
Alice Communications

Dr Marie Alice Dibon currently heads Alice Communications Inc. a consulting company, servicing various industries on strategy, business development, communication and innovation and established in 2000.

Before the creation of Alice Communications, Ms. Dibon spent 15 years in France and the United States in the beauty, pharmaceutical and medical device industries. Her experience ranges from product development to marketing, through regulatory affairs, business development and manufacturing.

Dr Marie Alice Dibon

Consultant
Alice Communications

Dr Marie Alice Dibon

Consultant
Alice Communications

Dr Marie Alice Dibon currently heads Alice Communications Inc. a consulting company, servicing various industries on strategy, business development, communication and innovation and established in 2000.

Before the creation of Alice Communications, Ms. Dibon spent 15 years in France and the United States in the beauty, pharmaceutical and medical device industries. Her experience ranges from product development to marketing, through regulatory affairs, business development and manufacturing.

Today Alice Communications focuses on promoting and deciphering science and  innovative technologies with industry and consumers for the benefit of the patient, consumer or industrial actors. 

Ms. Dibon holds a Masters in Industrial Pharmacy Institute of the Industrial Pharmacy Institute in Lyon and a Doctorate in Pharmacy from the Institute of Pharmaceutical and Biological Sciences of Lyon. She contributes regularly as an editor in the trade press on the topics of innovation, communication, science and technology, and their societal impacts

 

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

In 2003 he came to Henkel, where he worked, in the group of Hygiene Research, on different research projects, like the elucidation of the skin microbiota with molecular means. Since mid of 2009 Dr. Simmering acts as an internal consultant for the global Beauty Care business regarding all microbiological questions.

 

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard Paetzold Ph.D

Co-Founder & Chief Scientific Officer
S-Biomedic

Bernhard completed his PhD in synthetic biology, working together in collaboration with the pharmaceutical industry to engineer bacteria as a living pill. He is a scientific co-founder of S-Biomedic, and is leading the research and product development. 

His passion is understanding the complex interplay of the bacterial communities that live within and on us. He is fascinated by the untouched potential of active compounds that are naturally produced everyday right on our own skin.

 

Catherine O'Neill

CEO
SkinBioTherapeutics

Catherine O'Neill

CEO
SkinBioTherapeutics

Catherine O'Neill

CEO
SkinBioTherapeutics
 

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials.

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey Gueniche Ph.D

HEAD OF INTERNATIONAL SCIENTIFIC VALORISATION LUXURY DIVISION
L'Oréal

Audrey GUENICHE obtained her Pharmacist degree and her PhD degree in skin biology more than 23 years ago. She is an expert on immunology and microbiology. Her main expertise is on skin topical treatment and food supplement for skin and hair health, especially using probiotics, natural extract and bacterial extracts. She is currently a senior clinical expert in LOREAL RESEARCH. She has a complete experience from the actives through vitro evaluations/ preclinical studies to clinical trials. Her passion is to always reinvent evaluation and find new fields of area in term of actives to promote. 

She has published over 110 papers in peer-reviewed journals, 5 chapters in books, 2 specials issues in journal where she was the invited editor. She presented in over 80 international congresses and additionally she was personally invited to give more than 35 keynote lectures.

 

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar Claes, PhD

Chief Scientific Officer
YUN Probiotherapy

Ingmar studied bioscience engineering at the University of Leuven, graduated in 2007 and obtained a PhD in cell and gene technology in 2011. He has an expertise in the field of probiotics, its molecular mechanisms and the topical application of these beneficial bacteria to restore the human microbiome. As bioengineer and microbiologist, he feels that it is important to translate this scientific research into daily products from which people at home and the community can benefit.

In the context of YUN, he is closely working together with the Department of Bioscience Engineering of the University of Antwerp, the Lab of Applied Microbiology and Biotechnology of prof. Sarah Lebeer, the Lab of Pharmaceutical Technology and Biopharmacy of prof. Filip Kiekens, prof. dr. Julien Lambert (dermatology) and dr. Gilbert Donders (gynaecology, the University Hospital of Antwerp).

He has experience with leadership in multiple R&D projects and he held a managing role in YUN’s R&D projects of the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (VLAIO). YUN’s current range of probiotic products and therapies were developed under his supervision.

 

 

Sophie Seite

Scientific Director
La Roche Posay

Sophie Seite

Scientific Director
La Roche Posay

Sophie Seite

Scientific Director
La Roche Posay
 

Nigel Lawmon

Global Commercial Director
Feelunique

Nigel Lawmon joined Feelunique as Commercial Director in 2015, and now has over 22 years retail experience including department store, travel retail and speciality retail, including 17+ years in the beauty industry. 

Nigel’s expertise quickly enhanced Feelunique’s business commercially and enhanced the brand offering, that has significantly increased its sales.

Prior to joining Feelunique Nigel was Managing Director of The Fragrance Shop and has previously held leadership roles at Debenhams and Alpha Retail/World Duty Free.

Nigel Lawmon

Global Commercial Director
Feelunique

Nigel Lawmon

Global Commercial Director
Feelunique

Nigel Lawmon joined Feelunique as Commercial Director in 2015, and now has over 22 years retail experience including department store, travel retail and speciality retail, including 17+ years in the beauty industry. 

Nigel’s expertise quickly enhanced Feelunique’s business commercially and enhanced the brand offering, that has significantly increased its sales.

Prior to joining Feelunique Nigel was Managing Director of The Fragrance Shop and has previously held leadership roles at Debenhams and Alpha Retail/World Duty Free.

 

Mark Wilson

Chief Executive Officer
MatriSys BioScience

Mark Wilson

Chief Executive Officer
MatriSys BioScience

Mark Wilson

Chief Executive Officer
MatriSys BioScience
 

Chris Gummer

Director
Cider Solutions

After 21 years as a senior technologist with Procter & Gamble Research & Development, Chris is now working for his own consultancy (Cider Solutions).

Chris Gummer

Director
Cider Solutions

Chris Gummer

Director
Cider Solutions

After 21 years as a senior technologist with Procter & Gamble Research & Development, Chris is now working for his own consultancy (Cider Solutions).

He has extensive experience in copy claim development and claim substantiation with some of the world’s leading consumer brands.  His experience ranges from fundamental research, hands-on development of data and methods, through to copy development and product credentialing.  Importantly, he has extensive experience in working with the Clearcast (formerly BACC) and the ASA from the position of an advertiser. He is a widely published and quoted author.

 

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Dr Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Mark Offerhaus

Chief Executive Officer
Micreos

Mark Offerhaus is founder and CEO of Dutch biotech Micreos. The company's endolysin technology, marketed under the Gladskin brand, enables targeted killing of unwanted bacteria while preserving the microbiome. 

Before starting Micreos, Mark worked at ING for over ten years, including 5 years in Japan. 

Mark Offerhaus

Chief Executive Officer
Micreos

Mark Offerhaus

Chief Executive Officer
Micreos

Mark Offerhaus is founder and CEO of Dutch biotech Micreos. The company's endolysin technology, marketed under the Gladskin brand, enables targeted killing of unwanted bacteria while preserving the microbiome. 

Before starting Micreos, Mark worked at ING for over ten years, including 5 years in Japan. 

 

Daniela Pinto

Scientist
Giuliani

Daniela Pinto

Scientist
Giuliani

Daniela Pinto

Scientist
Giuliani
 

Larry Weis

CSO & Founder
Symbiome

 

Larry Weis

CSO & Founder
Symbiome

Larry Weis

CSO & Founder
Symbiome

 

 

Olga Francino Marti

Founding Partners
Vetgenomics

Ph.D. in Genetics from the Universitat Autònoma de Barcelona (UAB) with broad experience in molecular biology and animal genomics.  Project Management and Innovation at the Molecular Genetics Veterinary Service (SVGM) of the UAB since its creation in 1996. Founding partner of Vetgenomics (2011), a technology-based company focused on genetic diagnostic and genomics.  

Olga Francino Marti

Founding Partners
Vetgenomics

Olga Francino Marti

Founding Partners
Vetgenomics

Ph.D. in Genetics from the Universitat Autònoma de Barcelona (UAB) with broad experience in molecular biology and animal genomics.  Project Management and Innovation at the Molecular Genetics Veterinary Service (SVGM) of the UAB since its creation in 1996. Founding partner of Vetgenomics (2011), a technology-based company focused on genetic diagnostic and genomics.  

With extensive experience in the design and implementation of new methodologies of genetic analysis as well as to their valorization. Responsible for numerous agreements and projects with companies of the pharmaceutical and agrigenomics fields and currently working in national and international collaborations on infectious diseases, pathogens, and microbiome characterization with NGS.

 

 

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

 Harald van der Hoeven started to work in personal care in 1999 where he specialized on R&D and formulating of skin care cosmetics.

In 2006 Harald joined CLR in Berlin and took over as Director R&D. Since May 2013 he is Technical Marketing Director at CLR, involved in both R&D and technical and scientific support of CLR's customers.

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

Harald van der Hoeven

Director Technical Marketing
CLR - Berlin

 Harald van der Hoeven started to work in personal care in 1999 where he specialized on R&D and formulating of skin care cosmetics.

In 2006 Harald joined CLR in Berlin and took over as Director R&D. Since May 2013 he is Technical Marketing Director at CLR, involved in both R&D and technical and scientific support of CLR's customers.

 

Sabrina Okombi

Project Leader
BASF

Sabrina has a background of Pharmacist, completed by a PhD in medicinal chemistry.

During 8 years, she held a position of project manager, and developed several models for the evaluation of the biological efficacy of active ingredient for cosmetic applications.

Since more than one year, she has been leading projects and an innovation platform dedicated to the skin microbiota and their application in skin care.

Sabrina Okombi

Project Leader
BASF

Sabrina Okombi

Project Leader
BASF

Sabrina has a background of Pharmacist, completed by a PhD in medicinal chemistry.

During 8 years, she held a position of project manager, and developed several models for the evaluation of the biological efficacy of active ingredient for cosmetic applications.

Since more than one year, she has been leading projects and an innovation platform dedicated to the skin microbiota and their application in skin care.

 

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni Ph.D

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

In 2001, she created VitroScreen, a research laboratory committed to in vitro science that has the mission to be a reference partner for companies approaching in vitro alternatives, providing in vitro pre-clinical efficacy and regulatory toxicological services.

At VitroScreen she has developed “mechanism based experimental models“ on 3D reconstructed human tissue models for active ingredients and finished product testing: this approach better mimics the in vivo skin and epithelia response taking into account the dynamic of the biological response. VitroScreen is GLP certified and a member of the EU-Netval national reference laboratory network.

 

Peter Bogaert

Managing Partner
Covington & Burling

Peter Bogaert is a managing partner of the Brussels office, and has a broad European life sciences practice. He has detailed regulatory expertise under EU and national laws, handles legislative and other policy assignments and provides strategic advice. He also represents life sciences companies before the European Courts in Luxembourg and in local litigation in Belgium. Mr.

Peter Bogaert

Managing Partner
Covington & Burling

Peter Bogaert

Managing Partner
Covington & Burling

Peter Bogaert is a managing partner of the Brussels office, and has a broad European life sciences practice. He has detailed regulatory expertise under EU and national laws, handles legislative and other policy assignments and provides strategic advice. He also represents life sciences companies before the European Courts in Luxembourg and in local litigation in Belgium. Mr. Bogaert's practice covers pharmaceuticals, biotechnology, medical devices, special foods and feed, cosmetics and other consumer products and he represents numerous innovative life sciences companies, including start-ups, as well as several industry associations.

 

Silvia Balzaretti

Scientist
VitroScreen

Silvia Balzaretti

Scientist
VitroScreen

Silvia Balzaretti

Scientist
VitroScreen

The Agenda

Simply fill in this form and we'll send you a PDF version of the agenda immediately. We need some information to know where to send the file and how to address our email to you.

Check out the highlights from our inaugural Skin Microbiome Congress earlier this year: 

Beauty & Money Summit 2018

Download Full Agenda

Headline Partner

Thought Leadership Partner

Associate Partner

Media Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Venue

ILEC Conference Centre and Ibis London Earls Court, 47 Lillie Road, London, SW6 1UD

Europe's first Skin Microbiome Congress will be co-located with the European Microbiome Congress in ILEC Conference Centre in London. 

The ILEC and Ibis London is based in the heart of West London and only a short ride away from London greatest landmarks, the venue is an ideal location for UK and overseas visitors.

Book now: 

Guests can book the best available rate by calling + 44 (0)207 666 8495 or email [email protected] quoting Kisaco Research.

Subject to availability.

ILEC

Accessibility:

We are committed to making our event accessible for everyone. If you are traveling for the event, Cloud of Goods provides mobility scooter rentals, wheelchair rentals, and other mobility solutions. They will deliver directly to you at the event, your hotel, the airport, or any other place of your choosing. Event attendees will receive a 20% discount when they use the code: RENTGEAR032

Visit: https://www.cloudofgoods.com/ 

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.